Literature DB >> 24452824

Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.

Iglika Vassileva1, Vihra Milanova, Turan Asan.   

Abstract

The purpose of this study is to assess the adherence status and to identify the risk factors for medication non-adherence in Bulgarian outpatients with schizophrenia. Variables with possible impact on adherence behaviour were assessed via a set of pre-determined clinical interviews and self-rating scales in a total of 226 patients with schizophrenia. As non-adherent were classified 55.8% of the participants. Differences between adherent and non-adherent patients were identified. A multiple regression analysis revealed three variables predictive for the medication adherence--attitudes toward medication, severity of positive symptoms and the ability to recognize psychotic symptoms. Interventions focusing on the identified predictive variables might be useful when aiming at improvement of medication adherence and outcome in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452824     DOI: 10.1007/s10597-014-9697-8

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  58 in total

Review 1.  Interventions to improve medication adherence in schizophrenia.

Authors:  Annette Zygmunt; Mark Olfson; Carol A Boyer; David Mechanic
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

2.  The assessment of insight in psychosis.

Authors:  A David; A Buchanan; A Reed; O Almeida
Journal:  Br J Psychiatry       Date:  1992-11       Impact factor: 9.319

3.  Completed suicide in schizophrenia: evidence from a case-control study.

Authors:  Maurizio Pompili; David Lester; Alessandro Grispini; Marco Innamorati; Fulvia Calandro; Paolo Iliceto; Eleonora De Pisa; Roberto Tatarelli; Paolo Girardi
Journal:  Psychiatry Res       Date:  2009-04-23       Impact factor: 3.222

4.  Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E).

Authors:  P M Dingemans; D H Linszen; M E Lenior; R M Smeets
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

5.  Correlates, change and 'state or trait' properties of insight in schizophrenia.

Authors:  Benjamin D R Wiffen; Jonathan Rabinowitz; Alice Lex; Anthony S David
Journal:  Schizophr Res       Date:  2010-04-10       Impact factor: 4.939

6.  Use patterns for antipsychotic medications in medicaid patients with schizophrenia.

Authors:  J S McCombs; M B Nichol; G L Stimmel; J Shi; R R Smith
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

7.  Substance abuse and the management of medication nonadherence in schizophrenia.

Authors:  Joshua Wilk; Steven C Marcus; Joyce West; Lisa Countis; Rebecca Hall; Darrel A Regier; Mark Olfson
Journal:  J Nerv Ment Dis       Date:  2006-06       Impact factor: 2.254

8.  Survey of medication adherence in patients with schizophrenia--Korean ADHES data.

Authors:  Sung-Wan Kim; Jin-Sang Yoon; Sung-Ku Choi
Journal:  Hum Psychopharmacol       Date:  2006-12       Impact factor: 1.672

9.  Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.

Authors:  Somaia Mohamed; Robert Rosenheck; Joseph McEvoy; Marvin Swartz; Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

10.  The role of the helping alliance in psychiatric community care. A prospective study.

Authors:  S Priebe; T Gruyters
Journal:  J Nerv Ment Dis       Date:  1993-09       Impact factor: 2.254

View more
  7 in total

1.  Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla).

Authors:  Ulrike Stentzel; Neeltje van den Berg; Lara N Schulze; Thea Schwaneberg; Franziska Radicke; Jens M Langosch; Harald J Freyberger; Wolfgang Hoffmann; Hans-Jörgen Grabe
Journal:  BMC Psychiatry       Date:  2018-05-29       Impact factor: 3.630

Review 2.  Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders.

Authors:  Elizabeth S Smith; Joshua E Porterfield; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2019-03-04       Impact factor: 15.470

3.  Correlates of Negative Attitudes towards Medication in People with Schizophrenia.

Authors:  Lucie Kondrátová; Daniel König; Karolína Mladá; Petr Winkler
Journal:  Psychiatr Q       Date:  2019-03

4.  Adherence to antipsychotic medication among homeless adults in Vancouver, Canada: a 15-year retrospective cohort study.

Authors:  Stefanie N Rezansoff; A Moniruzzaman; S Fazel; R Procyshyn; J M Somers
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-06-23       Impact factor: 4.328

5.  Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia.

Authors:  Minale Tareke; Siranesh Tesfaye; Desalegn Amare; Tilahun Belete; Andargie Abate
Journal:  S Afr J Psychiatr       Date:  2018-03-05       Impact factor: 1.550

6.  Testing the hypothesis of subtypes of nonadherence in schizophrenia and schizoaffective disorder: A prospective study.

Authors:  Dulcinea Vega; Francisco J Acosta; Pedro Saavedra
Journal:  World J Psychiatry       Date:  2020-11-19

7.  Feedback on SMS reminders to encourage adherence among patients taking antipsychotic medication: a cross-sectional survey nested within a randomised trial.

Authors:  Kati Anneli Kannisto; Clive E Adams; Marita Koivunen; Jouko Katajisto; Maritta Välimäki
Journal:  BMJ Open       Date:  2015-11-09       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.